Virtu KCG Holdings’s Phio Pharmaceuticals PHIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$45K Hold
1
– – ﹤0.01% 2615
2017
Q1
$47K Buy
+1
New +$43.2K ﹤0.01% 2854
2016
Q4
– Hold
0
– – – 3231
2016
Q2
– Hold
0
– -$43K – 3242
2016
Q1
– Hold
0
– – – 2492
2015
Q4
– Hold
0
– – – 3270
2015
Q3
– Hold
0
– – – 3051
2015
Q2
– Hold
0
– – – 3069
2015
Q1
– Hold
0
– – – 2989
2014
Q4
– Hold
0
– – – 3356
2014
Q3
– Hold
0
– -$167K – 3942
2014
Q2
– Hold
0
– – – 3138

Other funds holding PHIO

Virtu KCG Holdings's PHIO Position: Q2 2017 in Review

Virtu KCG Holdings held its Phio Pharmaceuticals (PHIO) position steady in Q2 2017 at 1 share worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Virtu KCG Holdings first reported a position in PHIO in Q1 2017 and has held it in 2 quarters since. The position peaked at $47K in Q1 2017. 5 funds tracked by Wall St. Rank hold PHIO as of Q2 2017.

  • Virtu KCG Holdings held 1 share of Phio Pharmaceuticals worth $45K as of Q2 2017.
  • Virtu KCG Holdings left its Phio Pharmaceuticals share count unchanged in Q2 2017.
  • Phio Pharmaceuticals made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2615 holding.
  • Virtu KCG Holdings first reported a position in Phio Pharmaceuticals in Q1 2017 and has held it in 2 quarters since.
  • Virtu KCG Holdings's Phio Pharmaceuticals position peaked at $47K in Q1 2017.
  • 5 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.